• 09.25.17

    Manatt Leads Rosco, Inc. to Patent Infringement Settlement

    Manatt represented Rosco, Inc. in a patent infringement suit against its competitor Rostra Precision Controls, Inc. in the United States District Court, Southern District of New York.   Rosco is one of North America’s leading suppliers of backup camera systems, mirrors and visors to ...

  • 09.25.17

    The Theory of Implied Certification Post-Escobar

    Manatt’s Jacqueline Wolff, co-chair of the firm’s corporate investigations and white collar defense practice, was interviewed by Health Law Daily for an article on implied certification in cases since Universal Health Services, Inc. v. U.S. ex rel. Escobar.The publication notes that in ...

  • 09.25.17

    Manatt Health’s Cindy Mann Testifies at Senate Finance Committee Hearing on Graham-Cassidy

    Discussion Sets the Stage for the Future of Healthcare Reform in 2017Manatt partner Cindy Mann, who has over 30 years of federal- and state-level experience in health policy, today testified in opposition to Graham-Cassidy at the United States Senate Committee on Finance’s hearing to consider ...

  • 09.25.17

    Failed ACA Repeal Efforts Could Indicate a Pause

    Manatt’s Joel Ario, a managing director with Manatt Health, was quoted by Law360 in an article discussing the latest Affordable Care Act repeal efforts.Law360 noted that the Senate’s failure to move the Graham-Cassidy bill forward will likely result in pausing similar efforts for the ...

  • 09.21.17

    How Some States Could Benefit From Graham-Cassidy

    The Hill quoted Manatt’s Jocelyn Guyer, a managing director with Manatt Health, in an article analyzing how the new Affordable Care Act repeal and replace legislation could financially impact various states.The publication explained that states with lower healthcare costs could see funding ...

  • 09.20.17

    Manatt Named a Finalist for 2017 M&A Advisor Awards

    The M&A Advisor, a preeminent organization focused on offering insights and intelligence on mergers and acquisitions, has named Manatt a finalist for its 16th annual M&A Awards. The awards recognize the leading M&A transactions, restructurings, deal financings, product/services, firms ...

  • 09.20.17

    Measuring Compliance: Gathering and Analyzing Data

    Manatt’s Jacqueline Wolff, co-chair of the firm’s corporate investigations and white collar defense practice, was interviewed for The Anti-Corruption Report’s final installment of a four-part series on measuring corporate compliance. The fourth piece discussed continuously ...

  • 09.20.17

    Graham-Cassidy Proposal Leaves Room for Questions

    Modern Healthcare quoted Manatt’s Patricia Boozang, senior managing director with Manatt Health, on how the Graham-Cassidy repeal and replace legislation could impact states financially.   According to Manatt Health’s analysis, which was also featured by the publication, states ...

  • 09.20.17

    Losses Under Graham-Cassidy Between ‘Significant and Vast’

    Manatt’s Jocelyn Guyer, a managing director with Manatt Health, was quoted in the Los Angeles Times on how the Graham-Cassidy proposal could impact funding for healthcare in certain states.   Healthcare safety nets in dozens of states could stand to lose more than $200 billion by 2026 ...

  • 09.20.17

    New York Times Cites Manatt Health’s Graham-Cassidy Analysis

    Manatt Health’s analysis of the Graham-Cassidy bill was cited by the New York Times in an article discussing the health insurance industry’s reaction to the proposed legislation. The publication noted that the industry came out forcefully against the bill, suggesting that state-by-state ...

manatt-black

ATTORNEY ADVERTISING

pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved